Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

IDENIX PHARMACEUTICALS INC (IDIX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-13Dec-31-12Dec-31-11Dec-31-10Dec-31-09Dec-31-08Dec-31-07Dec-31-06
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues:  
    Collaboration revenue-related party  0.533.64.3     
    Collaboration revenue — related party       9.8  
    Other   36.12.6  0.2  
Total revenues   [+]0.569.77.010.212.610.068.067.4
            Revenue growth   [+]-99.3%902.2%-32.0%-19.0%25.5%-85.2%1.0%4.1%
Cost of goods sold  0.72.72.32.82.21.72.00.1
Gross profit  -0.267.04.67.510.48.366.067.3
            Gross margin  -52.5%96.2%66.6%73.0%82.5%82.6%97.1%99.9%
Selling, general and administrative   [+]35.324.216.723.421.527.163.357.0
Research and development  84.370.241.344.541.953.985.8 
Other operating expenses  -2.3      96.1
EBITDA   [+]-115.8-24.2-49.2-55.9-47.7-67.3-74.2-82.3
            EBITDA margin  -24691.5%-34.8%-707.9%-547.0%-378.4%-669.8%-109.1%-122.1%
Depreciation and amortization  1.73.14.24.65.25.49.03.5
EBIT   [+]-117.5-27.3-53.4-60.5-52.9-72.7-83.2-85.7
            EBIT margin  -25057.6%-39.2%-768.3%-591.7%-419.5%-723.6%-122.2%-127.2%
Non-recurring items   [+]6.28.0 2.21.50.38.7 
Other income (expense), net  1.32.91.41.11.32.8174.29.5
Pre-tax income  -122.4-32.5-52.0-61.6-53.2-70.282.3-76.2
Income taxes  -0.1-0.1-0.10.00.10.0-0.2-1.1
            Tax rate  0.1%0.3%0.1%0.1%   1.5%
Net income  -122.3-32.4-52.0-61.6-53.2-70.2-82.5-75.1
            Net margin  -26074.0%-46.5%-747.8%-602.2%-421.8%-698.6%-121.3%-111.4%
   
Basic EPS   [+]($0.91)($0.27)($0.57)($0.87)($0.87)($1.24)($1.47)($1.34)
Diluted EPS   [+]($0.91)($0.27)($0.57)($0.87)($0.87)($1.24)($1.47)($1.34)
   
Shares outstanding (basic)   [+]134.0118.890.870.761.556.456.256.0
Shares outstanding (diluted)   [+]134.0118.890.870.761.556.456.256.0
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy